Myeloproliferative Neoplasms Clinical Trial
Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention
Summary
The purpose of this study is to evaluate Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) with fatigued chronic myelogenous leukemia (CML) patients on tyrosine kinase inhibitors (TKIs) for feasibility, acceptability and potential efficacy relative to usual care only in a small-scale randomized controlled trial.
Eligibility Criteria
Inclusion Criteria:
able to speak/read English
diagnosed with chronic phase CML
not have been treated for other cancer (except non-melanoma skin cancer) in the past 5 years
be under the care of a Moffitt Cancer Center (MCC) physician
be on a stable dose of the same oral TKI for >= 3 months
new onset or worsening of fatigue since starting TKI
report moderate-severe fatigue in past week (FSI average rating >= 4 of 0-10)
have no clinical history of disease (e.g., multiple sclerosis, fibromyalgia) that could account for their fatigue presentation
Exclusion Criteria:
scheduled to discontinue their TKI under medical supervision within the next 3 months
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Tampa Florida, 33612, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.